India Approves First Dengue Vaccine: What Takeda's Qdenga Means For Patients & Vaccine Makers

India has approved its first dengue vaccine, Takeda's Qdenga, marking a major milestone in the country's fight against dengue. The regulatory clearance is expected to improve disease prevention while also setting a benchmark for future dengue vaccine approvals in India. Neetu Chandra Sharma, Business Today, explains that the approval could accelerate the development of indigenous vaccine candidates, including Panacea Biotec's Phase 3 program in collaboration with ICMR. As India remains one of the world's largest dengue-affected countries, the decision could boost investment, intensify competition among vaccine makers, and pave the way for wider public immunisation efforts in the future